Investigating how HPV genes cause mutations linked to cervical cancer

Defining the ability of HPV oncogenes to promote mutagenesis

NIH-funded research Kansas State University · NIH-10894615

This study is looking at how certain HPV genes might cause changes in our DNA that can lead to cervical cancer, and it’s for anyone interested in understanding how HPV affects the body and contributes to cancer development.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionKansas State University NIH-funded
Lab location1 site (Manhattan, United States)
Project IDNIH-10894615 on NIH RePORTER

What this research studies

This research explores the role of HPV oncogenes, specifically E6 and E7, in causing mutations that lead to cervical cancer. It examines whether these genes actively disrupt DNA repair processes or passively degrade tumor suppressors like p53 and RB. By analyzing how HPV influences the repair of DNA double-strand breaks, the research aims to determine if HPV makes these repairs more error-prone, potentially leading to cancer. The findings could provide insights into the mechanisms of HPV-related tumorigenesis.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with persistent HPV infections, particularly those at risk for developing cervical cancer.

Not a fit: Patients who do not have HPV infections or those with cervical cancer unrelated to HPV may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding of cervical cancer development and potential new strategies for prevention or treatment.

How similar studies have performed: While the role of HPV in cervical cancer is well-established, the specific mechanisms of how HPV oncogenes promote mutagenesis are still being explored, making this research a novel investigation.

Where this research is happening

Manhattan, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acute Radiation SyndromeCancer GenesCancer-Promoting GeneCancers
Last reviewed 2026-06-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.